Notice on the 2024 Annual General Meeting
Filed with SSE · · 7 pages · Chinese
Shanghai Haixin Group Co., Ltd. on 6ix
Earlier from Shanghai Haixin
- Report for Q1 2025
- Announcement on Change of Accounting Policies
- Announcement on Subsidiary Obtaining Drug Registration Certificate and Notice of Approval for Marketing Application of API
- Announcement on Completing Registration Change of Legal Representative
- Announcement on Resolutions of the 7th Meeting of the 11th Board of Directors
Later from Shanghai Haixin
- Announcement on Resignation of Chairman of Board of Supervisors
- Announcement on Resolutions of the 2024 Annual General Meeting
- Announcement on Progress of Investment in Industrial Fund Projects
- Announcement on Progress in Transferring Equity of Shanghai Haixin Pharmaceuticals Co., Ltd.
- Announcement on Implementation of Dividend Distribution for 2024
Follow Shanghai Haixin into a list and get an email when it puts out news.
Follow Shanghai Haixin